Clinical trial
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are…
NCT00048971 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00048971 |
|---|---|
| Title | Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy |
| Official title | A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Colorectal Cancer, Diarrhea, Neutropenia |
| Intervention type | Genetic |
| Interventions | mutation analysis, polymorphic microsatellite marker analysis |
| Enrollment | 308 |
| Start date | Apr 1, 2002 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 6, 2016 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: